Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Ishares Nasdaq Biotechnology ETF (NQ: IBB)
137.35 USD  -1.86 (-1.34%)
Official Closing Price  /  Updated: 7:41 PM EDT, Jul 13, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Ishares Nasdaq Biotechnology ETF
Sector
Exchange Traded NQ
Net Assets 11.94B
Inception Date
Related Funds
Quote
Price 137.35
Volume 4,882,576
Last Trade Jul 13, 7:41pm
Change (%)
-1.86 (-1.34%)
Prev. Close 139.21
YTD %
+14.56%
Dividend Yield 0.23%
Performance
YTD
+17.46 (14.56%)
1 Month
+9.27 (7.24%)
3 Month
+22.86 (19.97%)
6 Month
+18.19 (15.27%)
1 Year
+31.27 (29.48%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Time to Watch Risk Appetite Through Junk Bonds
If risk appetite, which has already waned, continues to wane, watch JNK carefully. 100-101 is support to hold. If it breaks those levels, then a move near 95.00 and then 90.00 could happen swiftly. Read More
from Blogs - TalkMarkets
Stock ETFs Build On Friday Gains, Ignoring Florida Virus Spike
Stocks and index ETFs are surging on Monday, building on the gains made Friday, as investors once again eschew the spiking coronavirus cases and push stocks higher in a plethora of market sectors. The... Read More
from ETF Trends
Top News
More News
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector. FDA approved a few drugs, ... Read More
from Benzinga
3 Top Healthcare Stocks to Buy Right Now
These pioneers will be winners however the pandemic plays out. Read More
from Motley Fool
Market Offers New Growth Amidst The Dead Wood
Perhaps the most incredible aspect of the market and for traders, is the ever-changing landscape of investment opportunities. I spend a lot of time telling followers that the rules have changed. Read More
from Blogs - TalkMarkets
Stock ETFs Rally In Mixed Trade Amid Vaccine Developments
Stocks and index ETFs are mixed to higher in choppy trading Friday as traders are processing headlines that a potential coronavirus treatment could be in the works, as well as another historic surge in... Read More
from ETF Trends
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Granny Retail Hangs Tough
On the weekly chart, XRT is above the 200-week moving average. The 10-DMA is starting to accelerate and just crossed over the 50-WMA. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Island Bottom, Momentum And Buffett
Rare to see an island bottom. However, the one in UNG or the ETF for natural gas had a classic one. Read More
from Blogs - TalkMarkets
Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research
Biotechnology sector-related exchange traded funds were among the best performers Tuesday as the government program “Operation Warp Speed” allocates billions of dollars for a quick development and... Read More
from ETF Trends
Fabulous Fundamentals Brighten Outlook for Healthcare
The ALPS Medical Breakthroughs ETF ( SBIO ) is higher by almost 39% over the past 90 days. Importantly, that impressive move is underpinned by strong fundamentals throughout the broader healthcare... Read More
from ETFdb
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Random Thoughts On The New Bullish Market Calls
While there was a big boost from Nasdaq on Monday, the “inside” sectors are not yet believing the tech sector tells the whole story. Read More
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.